These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 18201230

  • 1. Immunohistochemistry in ocular carcinomas.
    Sramek B, Lisle A, Loy T.
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM, Cabral E, Dadras SS, Cassarino DS.
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [Abstract] [Full Text] [Related]

  • 3. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S, Takeichi H, Arase S, Kawana S, Kimura T.
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [Abstract] [Full Text] [Related]

  • 4. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS, Carr RA, Sanders DS, Smith AP, Lazar AJ, Calonje E.
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D, Sellheyer K.
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
    Bayer-Garner IB, Givens V, Smoller B.
    Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
    [Abstract] [Full Text] [Related]

  • 7. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R, Araujo I, Czanner G, Coupland SE.
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [Abstract] [Full Text] [Related]

  • 8. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
    Heyl J, Mehregan D.
    J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
    [Abstract] [Full Text] [Related]

  • 9. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R, Shahsiah R.
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S, Arase S, Kawana S, Kimura T.
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [Abstract] [Full Text] [Related]

  • 11. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
    Chen WS, Chen PL, Li J, Lind AC, Lu D.
    J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH.
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [Abstract] [Full Text] [Related]

  • 13. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
    Sellheyer K, Krahl D.
    J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
    Misago N, Narisawa Y.
    J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
    [Abstract] [Full Text] [Related]

  • 15. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S.
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [Abstract] [Full Text] [Related]

  • 16. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin.
    Beer TW, Shepherd P, Theaker JM.
    Histopathology; 2000 Sep; 37(3):218-23. PubMed ID: 10971697
    [Abstract] [Full Text] [Related]

  • 17. Dimorphic immunohistochemical staining in ocular sebaceous neoplasms: a useful diagnostic aid.
    Johnson JS, Lee JA, Cotton DW, Lee WR, Parsons MA.
    Eye (Lond); 1999 Sep; 13 ( Pt 1)():104-8. PubMed ID: 10396393
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA, Werdich X.
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [Abstract] [Full Text] [Related]

  • 19. Profiles of keratin proteins in basal and squamous cell carcinomas of the skin. An immunohistochemical study.
    Thomas P, Said JW, Nash G, Banks-Schlegel S.
    Lab Invest; 1984 Jan; 50(1):36-41. PubMed ID: 6198559
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
    Murata T, Nakashima Y, Takeuchi M, Sueishi K, Inomata H.
    Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.